These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 27943021

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interaction of microtubule depolymerizing agent indanocine with different human αβ tubulin isotypes.
    Kumbhar BV, Panda D, Kunwar A.
    PLoS One; 2018; 13(3):e0194934. PubMed ID: 29584771
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. βII-tubulin and βIII-tubulin mediate sensitivity to peloruside A and laulimalide, but not paclitaxel or vinblastine, in human ovarian carcinoma cells.
    Kanakkanthara A, Northcote PT, Miller JH.
    Mol Cancer Ther; 2012 Feb; 11(2):393-404. PubMed ID: 22180309
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity.
    Gan PP, Kavallaris M.
    Cancer Res; 2008 Dec 01; 68(23):9817-24. PubMed ID: 19047161
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of tubulin isotypes and mutations from taxol-resistant cells by combined isoelectrofocusing and mass spectrometry.
    Verdier-Pinard P, Wang F, Martello L, Burd B, Orr GA, Horwitz SB.
    Biochemistry; 2003 May 13; 42(18):5349-57. PubMed ID: 12731876
    [Abstract] [Full Text] [Related]

  • 12. Computational study of interactions of anti-cancer drug eribulin with human tubulin isotypes.
    Rai K, Kumbhar BV, Panda D, Kunwar A.
    Phys Chem Chem Phys; 2022 Jul 13; 24(27):16694-16700. PubMed ID: 35766982
    [Abstract] [Full Text] [Related]

  • 13. Delineating the interaction of combretastatin A-4 with αβ tubulin isotypes present in drug resistant human lung carcinoma using a molecular modeling approach.
    Kumbhar BV, Bhandare VV, Panda D, Kunwar A.
    J Biomol Struct Dyn; 2020 Feb 13; 38(2):426-438. PubMed ID: 30831055
    [Abstract] [Full Text] [Related]

  • 14. Rationalization of paclitaxel insensitivity of yeast β-tubulin and human βIII-tubulin isotype using principal component analysis.
    Das L, Bhattacharya B, Basu G.
    BMC Res Notes; 2012 Aug 01; 5():395. PubMed ID: 22849332
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanism of action of ixabepilone and its interactions with the βIII-tubulin isotype.
    Lopus M, Smiyun G, Miller H, Oroudjev E, Wilson L, Jordan MA.
    Cancer Chemother Pharmacol; 2015 Nov 01; 76(5):1013-24. PubMed ID: 26416565
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Exploring the interaction of Peloruside-A with drug resistant αβII and αβIII tubulin isotypes in human ovarian carcinoma using a molecular modeling approach.
    Kumbhar BV, Bhandare VV.
    J Biomol Struct Dyn; 2021 Apr 01; 39(6):1990-2002. PubMed ID: 32241247
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A label-free mass spectrometry method for relative quantitation of β-tubulin isotype expression in human tumor tissue.
    Miller LM, Huang Yang CP, Xiao H, Isaac S, Sève P, Dumontet C, Band Horwitz S, Hogue Angeletti R.
    Proteomics Clin Appl; 2012 Oct 01; 6(9-10):502-6. PubMed ID: 22996942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.